These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9056742)

  • 21. Concordance of two approaches in monitoring of minimal residual disease in B-precursor acute lymphoblastic leukemia: Fusion transcripts and leukemia-associated immunophenotypes.
    Huang YJ; Coustan-Smith E; Kao HW; Liu HC; Chen SH; Hsiao CC; Yang CP; Jaing TH; Yeh TC; Kuo MC; Lai CL; Chang CH; Campana D; Liang DC; Shih LY
    J Formos Med Assoc; 2017 Oct; 116(10):774-781. PubMed ID: 28063722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD19 negative precursor B acute lymphoblastic leukemia (B-ALL)-Immunophenotypic challenges in diagnosis and monitoring: A study of three cases.
    Ghodke K; Bibi A; Rabade N; Patkar N; Subramanian PG; Kadam PA; Badrinath Y; Ghogale S; Gujral S; Tembhare P
    Cytometry B Clin Cytom; 2017 Jul; 92(4):315-318. PubMed ID: 27018867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens.
    Syrjälä M; Anttila VJ; Ruutu T; Jansson SE
    Leukemia; 1994 Sep; 8(9):1564-70. PubMed ID: 7522295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells.
    Hurwitz CA; Gore SD; Stone KD; Civin CI
    Leukemia; 1992 Apr; 6(4):233-9. PubMed ID: 1375301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FxCycle™ Based Ploidy Correlates with Cytogenetic Ploidy in B-Cell Acute Lymphoblastic Leukemia and Is Able to Detect the Aneuploid Minimal Residual Disease Clone.
    Gupta N; Parihar M; Banerjee S; Brahma S; Pawar R; Rath A; Shewale S; Singh M; Sasikumaran Nair Remani A; Krishnan S; Bhatacharyya A; Das A; Kumar J; Bhave S; Radhakrishnan V; Nair R; Chandy M; Mishra D; Arora N
    Cytometry B Clin Cytom; 2019 Sep; 96(5):359-367. PubMed ID: 30715800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of new markers for minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000-000.
    Tembhare PR; Ghogale S; Ghatwai N; Badrinath Y; Kunder N; Patkar NV; Bibi AR; Chatterjee G; Arora B; Narula G; Banawali S; Deshpande N; Amare P; Gujral S; Subramanian PG
    Cytometry B Clin Cytom; 2018 Jan; 94(1):100-111. PubMed ID: 27718302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow cytometric characterization of phenotype, DNA indices and p53 gene expression in 55 cases of acute leukemia.
    Powari M; Varma N; Varma S; Marwaha RK; Sandhu H; Ganguly NK
    Anal Quant Cytol Histol; 2002 Jun; 24(3):159-65. PubMed ID: 12102128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunologic monitoring in adults with acute lymphoblastic leukemia.
    Vidriales MB; Orfao A; San-Miguel JF
    Curr Oncol Rep; 2003 Sep; 5(5):413-8. PubMed ID: 12895394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Leukemia-associated immunophenotypes in 415 childhood and adult patients with B lineage acute lymphoblastic leukemia by multiparametric flow cytometry analysis].
    Liu YR; Chen SS; Chang Y; Fu JY; Zhang LP; Wang H; Li LD; Zhu HH; Liu GL; Lu DP; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):853-7. PubMed ID: 17096875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posttherapy surveillance of B-cell precursor acute lymphoblastic leukemia. Value of polymerase chain reaction and limitations of flow cytometry.
    Kallakury BV; Hartmann DP; Cossman J; Gootenberg JE; Bagg A
    Am J Clin Pathol; 1999 Jun; 111(6):759-66. PubMed ID: 10361511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
    Ciudad J; Orfao A; Vidriales B; Macedo A; Martínez A; González M; López-Berges MC; Valverde B; San Miguel JF
    Haematologica; 1998 Dec; 83(12):1069-75. PubMed ID: 9949623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Correlation of the t(9;22), t(12;21), and DNA hyperdiploid content with immunophenotype and proliferative rate of leukemic B-cells of pediatric patients with B-cell acute lymphoblastic leukemia].
    Quijano SM; Torres MM; Vásquez LE; Cuéllar GE; Romero ML; Martín EL; Linares A; Castaño S; Sarmiento IC; Cabrera E; Uribe GI; Andrade RE; Saavedra CE
    Biomedica; 2013; 33(3):468-86. PubMed ID: 24652183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometric DNA-quantification of three-color immunophenotyped cells for subpopulation specific determination of aneuploidy and proliferation.
    Oelschlaegel U; Freund D; Range U; Ehninger G; Nowak R
    J Immunol Methods; 2001 Jul; 253(1-2):145-52. PubMed ID: 11384676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiparametric analysis of normal and postchemotherapy bone marrow: Implication for the detection of leukemia-associated immunophenotypes.
    Olaru D; Campos L; Flandrin P; Nadal N; Duval A; Chautard S; Guyotat D
    Cytometry B Clin Cytom; 2008 Jan; 74(1):17-24. PubMed ID: 18061947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flow cytometric monitoring of residual disease in acute leukemia.
    Wood BL
    Methods Mol Biol; 2013; 999():123-36. PubMed ID: 23666694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A prognostic factor in childhood acute lymphoblastic leukemia: implication of cellular DNA contents. Children's Cancer and Leukemia Study Group].
    Katano N; Tsurusawa M; Kawai S; Fujimoto T
    Rinsho Ketsueki; 1989 Jul; 30(7):943-50. PubMed ID: 2810797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative analysis of blast immunophenotype between the diagnosis and relapse of childhood acute lymphoblastic leukaemia - implications for monitoring of minimal residual disease].
    Bulsa J; Sedek Ł; Sońta-Jakimczyk D; Mazur B; Sobol G; Szczepański T
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1045-50. PubMed ID: 19531824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement.
    Lin P; Jones D; Dorfman DM; Medeiros LJ
    Am J Surg Pathol; 2000 Nov; 24(11):1480-90. PubMed ID: 11075849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.
    Karawajew L; Dworzak M; Ratei R; Rhein P; Gaipa G; Buldini B; Basso G; Hrusak O; Ludwig WD; Henze G; Seeger K; von Stackelberg A; Mejstrikova E; Eckert C
    Haematologica; 2015 Jul; 100(7):935-44. PubMed ID: 26001791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Common acute lymphoblastic leukemia characterized by four different DNA stemlines with heterogeneity in RNA content, antigen expression and sensitivity to chemotherapy.
    Redner A; Grabowski E; Al-Katib A; Andreeff M
    Leuk Res; 1986; 10(6):671-6. PubMed ID: 3458978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.